SHXWF yields 6.28% · PFE yields 6.13%● Live data
📍 SHXWF pulled ahead of the other in Year 1
Combined, SHXWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHXWF + PFE for your $10,000?
Xinhua Winshare Publishing and Media Co., Ltd., together with its subsidiaries, engages in the publishing and distribution businesses in the People's Republic of China. The company operates in two segments, Publication and Distribution. The Publication segment publishes books, journals, audio-visual products, and digital products; provides printing services; and supplies printing materials. The Distribution segment distributes textbooks and supplementary materials to schools, teachers, and students; and supplies education informatization and equipment services for primary and secondary schools, as well as engages in the retail, distribution, and online sale of publications. The company also sells books, newspapers, journals, artwork, and electronic equipment, as well as electronic publications; produces audio and video tapes; and provides logistics, assets management, education ancillary, and business services. In addition, it is involved in the wholesale and retail of pre-packaged food and dairy products; import and export business; property leasing; catering and ticket agency; and advertising agency and leasing business. Further, the company engages in the wholesale and retail distribution of goods; project investment and management; and organizing and planning of cultural and art exchange activities. Additionally, it offers computer software development and system services; business consulting; travel agency and related services; study tour event planning, conference, and exhibition services. The company was formerly known as Sichuan Xinhua Winshare Chainstore Co., Ltd. and changed its name to Xinhua Winshare Publishing and Media Co., Ltd. in 2010. The company was founded in 2005 and is headquartered in Chengdu, the People's Republic of China. Xinhua Winshare Publishing and Media Co., Ltd. is a subsidiary of Sichuan Xinhua Publishing and Distribution Group Co., Ltd.
Full SHXWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.